On August 23 Transnetyx, Inc., based in Cordova, Tennessee, announced its acquisition of Laragen, Inc. The financial terms were not disclosed.
Laragen is a sequencing and genetic services company in Culver City, California. The company was founded in 1995.
Transnetyx, a portfolio company of Thompson Street Capital Partners, is a fully-automated genotyping resource for thousands of researchers in universities, hospitals and bioscience companies around the world. It has genotyped more than 20 million samples in 24 or 72 hours with 99.97% accuracy.
The addition of Laragen’s sanger sequencing and next-generation sequencing services to the Transnetyx solution suite will ultimately improve access to cutting-edge genetic services for leading research institutes around the world.
According to data captured in the LevinPro HC database, this acquisition marks the 93rd Laboratories, MRI and Dialysis transaction of 2023, and 49th in the diagnostic specialty.
